IPC Main Group
A61P 17/00 Drugs for dermatological disorders
Introduced: January 2000
Last revised: January 2006
Classification Context
- Section:
- HUMAN NECESSITIES
- Class:
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- Subclass:
- SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61P 17/02 for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/04 Antipruritics
- A61P 17/06 Antipsoriatics
- A61P 17/08 Antiseborrheics
- A61P 17/1 Anti-acne agents
- A61P 17/12 Keratolytics, e.g. wart or anti-corn preparations
- A61P 17/14 for baldness or alopecia
- A61P 17/16 Emollients or protectives, e.g. against radiation
- A61P 17/18 Antioxidants, e.g. antiradicals
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594